Cell‐free protein synthesis of a cytotoxic cancer therapeutic: Onconase production and a just‐add‐water cell‐free system

Biotherapeutics have many promising applications, such as anti‐cancer treatments, immune suppression, and vaccines. However, due to their biological nature, some biotherapeutics can be challenging to rapidly express and screen for activity through traditional recombinant methods. For example, difficult‐to‐express proteins may be cytotoxic or form inclusion bodies during expression, increasing the time, labor, and difficulty of purification and downstream characterization. One potential pathway to simplify the expression and screening of such therapeutics is to utilize cell‐free protein synthesis. Cell‐free systems offer a compelling alternative to in vivo production, due to their open and malleable reaction environments. In this work, we demonstrate the use of cell‐free systems for the expression and direct screening of the difficult‐to‐express cytotoxic protein onconase. Using cell‐free systems, onconase can be rapidly expressed in soluble, active form. Furthermore, the open nature of the reaction environment allows for direct and immediate downstream characterization without the need of purification. Also, we report the ability of a ”just‐add‐water“ lyophilized cell‐fee system to produce onconase. This lyophilized system remains viable after being stored above freezing for up to one year. The beneficial features of these cell‐free systems make them compelling candidates for future biotherapeutic screening and production.

[1]  R. Raines,et al.  Interaction of onconase with the human ribonuclease inhibitor protein. , 2008, Biochemical and biophysical research communications.

[2]  F. Baneyx Recombinant protein expression in Escherichia coli. , 1999, Current opinion in biotechnology.

[3]  Gary Walsh,et al.  Biopharmaceutical benchmarks 2014 , 2014, Nature Biotechnology.

[4]  Jill A Fisher,et al.  Peering into the pharmaceutical "pipeline": investigational drugs, clinical trials, and industry priorities. , 2015, Social science & medicine.

[5]  M. Jewett,et al.  Substrate replenishment and byproduct removal improve yeast cell-free protein synthesis. , 2014, Biotechnology journal.

[6]  A. Benito,et al.  A cytotoxic ribonuclease reduces the expression level of P-glycoprotein in multidrug-resistant cell lines , 2012, Investigational New Drugs.

[7]  Bradley C. Bundy,et al.  Lyophilized Escherichia coli-based cell-free systems for robust, high-density, long-term storage. , 2014, BioTechniques.

[8]  J. Stapleton,et al.  Cell‐free synthesis and maturation of [FeFe] hydrogenases , 2008, Biotechnology and bioengineering.

[9]  R. Raines,et al.  Cancer chemotherapy--ribonucleases to the rescue. , 2001, Chemistry & biology.

[10]  R. Sirdeshmukh,et al.  Entry into Cells and Selective Degradation of tRNAs by a Cytotoxic Member of the RNase A Family* , 2002, The Journal of Biological Chemistry.

[11]  Anna K. Hawes,et al.  Alternative fermentation conditions for improved Escherichia coli-based cell-free protein synthesis for proteins requiring supplemental components for proper synthesis , 2014 .

[12]  Rui Gan,et al.  Cell-free protein synthesis: applications come of age. , 2012, Biotechnology advances.

[13]  W. Ardelt,et al.  Amino acid sequence of an anti-tumor protein from Rana pipiens oocytes and early embryos. Homology to pancreatic ribonucleases. , 1991, The Journal of biological chemistry.

[14]  Vincent Noireaux,et al.  Synthesis of 2.3 mg/ml of protein with an all Escherichia coli cell-free transcription-translation system. , 2014, Biochimie.

[15]  G. D'alessio,et al.  Effective expression and purification of recombinant onconase, an antitumor protein , 1999, FEBS letters.

[16]  K. Berg,et al.  Reversal of doxorubicin resistance in breast cancer cells by photochemical internalization , 2006, International journal of cancer.

[17]  M. Donadelli,et al.  Onconase induces autophagy sensitizing pancreatic cancer cells to gemcitabine and activates Akt/mTOR pathway in a ROS-dependent manner. , 2015, Biochimica et biophysica acta.

[18]  Weichang Zhou,et al.  Mammalian cell cultures for biologics manufacturing. , 2014, Advances in biochemical engineering/biotechnology.

[19]  Bradley Charles Bundy,et al.  Cell-free unnatural amino acid incorporation with alternative energy systems and linear expression templates. , 2014, New biotechnology.

[20]  Frank F. Bier,et al.  Synthesis of membrane proteins in eukaryotic cell‐free systems , 2013 .

[21]  Junhao Yang,et al.  Rapid expression of vaccine proteins for B-cell lymphoma in a cell-free system. , 2005, Biotechnology and bioengineering.

[22]  Bradley C. Bundy,et al.  The emerging age of cell‐free synthetic biology , 2014, FEBS letters.

[23]  C. J. Murray,et al.  Microscale to Manufacturing Scale-up of Cell-Free Cytokine Production—A New Approach for Shortening Protein Production Development Timelines , 2011, Biotechnology and bioengineering.

[24]  J. Swartz,et al.  High yield cell-free production of integral membrane proteins without refolding or detergents. , 2008, Biochimica et biophysica acta.

[25]  W. Ardelt,et al.  Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes. , 2008, Current pharmaceutical biotechnology.

[26]  R. Raines,et al.  Ribonuclease A variants with potent cytotoxic activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  W. Ardelt,et al.  Cytotoxic activity of the amphibian ribonucleases onconase and r-amphinase on tumor cells from B cell lymphoproliferative disorders. , 2014, International journal of oncology.

[28]  D. Levin,et al.  Inhibition of protein chain initiation in eukaryotes by deacylated transfer RNA and its reversibility by spermine. , 1973, Biochimica et biophysica acta.

[29]  W. Ardelt,et al.  Enzymatic and structural characterisation of amphinase, a novel cytotoxic ribonuclease from Rana pipiens oocytes. , 2007, Journal of molecular biology.

[30]  James R. Swartz,et al.  Transforming biochemical engineering with cell-free biology , 2012 .

[31]  Gary Walsh,et al.  Biopharmaceutical benchmarks , 2000, Nature Biotechnology.

[32]  Chang-Gil Park,et al.  Cell‐free synthesis and multifold screening of Candida antarctica lipase B (CalB) variants after combinatorial mutagenesis of hot spots , 2011, Biotechnology progress.

[33]  X. Yao,et al.  Secretory expression of glycosylated and aglycosylated mutein of onconase from Pichia pastoris using different secretion signals and their purification and characterization. , 2009, FEMS yeast research.

[34]  Bradley C. Bundy,et al.  The incorporation of the A2 protein to produce novel Qβ virus‐like particles using cell‐free protein synthesis , 2012, Biotechnology progress.